ASTE vs. AZN

Last updated Apr 1, 2026

Compare and contrast key facts about Astec Industries, Inc. (ASTE) and AstraZeneca PLC (AZN).

Performance

ASTE vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Astec Industries, Inc. (ASTE) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

ASTE vs. AZN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ASTE Astec Industries, Inc.	24.56%	30.57%	-8.37%	-7.33%	-40.62%	20.47%	39.49%	40.91%	-47.94%	-12.65%
AZN AstraZeneca PLC	9.51%	43.30%	-0.62%	1.44%	19.14%	19.66%	3.12%	35.68%	13.86%	33.10%

Fundamentals

Market Cap ASTE : $1.25B AZN : $308.06B
EPS ASTE : $1.68 AZN : $6.55
PE Ratio ASTE : 31.99 AZN : 30.10
PEG Ratio ASTE : 0.17 AZN : 0.04
PS Ratio ASTE : 0.88 AZN : 5.24
PB Ratio ASTE : 1.83 AZN : 6.33
Total Revenue (TTM) ASTE : $1.41B AZN : $58.74B
Gross Profit (TTM) ASTE : $378.60M AZN : $48.11B
EBITDA (TTM) ASTE : $115.30M AZN : $19.83B

Returns By Period

In the year-to-date period, ASTE achieves a 24.56% return, which is significantly higher than AZN's 9.51% return. Over the past 10 years, ASTE has underperformed AZN with an annualized return of 2.51%, while AZN has yielded a comparatively higher 16.71% annualized return.

ASTE

• 1D: 4.56%
• 1M: -13.09%
• YTD: 24.56%
• 6M: 12.44%
• 1Y: 58.06%
• 3Y*: 10.72%
• 5Y*: -5.81%
• 10Y*: 2.51%

AZN

• 1D: 1.72%
• 1M: -5.39%
• YTD: 9.51%
• 6M: 31.22%
• 1Y: 37.92%
• 3Y*: 15.06%
• 5Y*: 17.44%
• 10Y*: 16.71%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ASTE vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASTE

ASTE Risk / Return Rank: 82
ASTE Sharpe Ratio Rank: 85
ASTE Sortino Ratio Rank: 83
ASTE Omega Ratio Rank: 77
ASTE Calmar Ratio Rank: 82
ASTE Martin Ratio Rank: 84

AZN

AZN Risk / Return Rank: 83
AZN Sharpe Ratio Rank: 83
AZN Sortino Ratio Rank: 81
AZN Omega Ratio Rank: 78
AZN Calmar Ratio Rank: 87
AZN Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASTE vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Astec Industries, Inc. (ASTE) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ASTE	AZN	Difference
Sharpe ratio Return per unit of total volatility	1.53	1.40	+0.12
Sortino ratio Return per unit of downside risk	2.25	2.07	+0.18
Omega ratio Gain probability vs. loss probability	1.26	1.27	-0.01
Calmar ratio Return relative to maximum drawdown	2.54	3.20	-0.66
Martin ratio Return relative to average drawdown	7.72	8.03	-0.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ASTE vs. AZN - Sharpe Ratio Comparison

The current ASTE Sharpe Ratio is 1.53, which is comparable to the AZN Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of ASTE and AZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ASTE	AZN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.53	1.40	+0.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.14	0.74	-0.88
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.06	0.67	-0.61
Sharpe Ratio (All Time) Calculated using the full available price history	0.15	0.51	-0.35

Correlation

The correlation between ASTE and AZN is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ASTE vs. AZN - Dividend Comparison

ASTE's dividend yield for the trailing twelve months is around 0.97%, less than AZN's 2.70% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ASTE Astec Industries, Inc.	0.97%	1.20%	1.55%	1.40%	1.21%	0.65%	0.95%	1.05%	1.39%	0.68%	0.59%	0.98%
AZN AstraZeneca PLC	2.70%	1.70%	2.27%	2.15%	2.12%	2.35%	2.80%	2.81%	3.69%	3.95%	5.01%	4.06%

Drawdowns

ASTE vs. AZN - Drawdown Comparison

The maximum ASTE drawdown since its inception was -89.53%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for ASTE and AZN.

Drawdown Indicators

	ASTE	AZN	Difference
Max Drawdown Largest peak-to-trough decline	-89.53%	-48.94%	-40.59%
Max Drawdown (1Y) Largest decline over 1 year	-21.86%	-12.24%	-9.62%
Max Drawdown (5Y) Largest decline over 5 years	-62.41%	-27.87%	-34.54%
Max Drawdown (10Y) Largest decline over 10 years	-62.54%	-27.87%	-34.67%
Current Drawdown Current decline from peak	-27.91%	-5.39%	-22.52%
Average Drawdown Average peak-to-trough decline	-39.39%	-11.39%	-28.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.18%	4.88%	+2.30%

Volatility

ASTE vs. AZN - Volatility Comparison

Astec Industries, Inc. (ASTE) has a higher volatility of 12.76% compared to AstraZeneca PLC (AZN) at 6.95%. This indicates that ASTE's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASTE	AZN	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.76%	6.95%	+5.81%
Volatility (6M) Calculated over the trailing 6-month period	25.67%	19.14%	+6.53%
Volatility (1Y) Calculated over the trailing 1-year period	38.24%	27.28%	+10.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	41.54%	23.83%	+17.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.77%	24.90%	+16.87%

Financials

ASTE vs. AZN - Profitability Comparison

The chart below illustrates the profitability comparison between Astec Industries, Inc. and AstraZeneca PLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ASTE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Astec Industries, Inc. reported a gross profit of 109.30M and revenue of 400.60M. Therefore, the gross margin over that period was 27.3%.

AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AstraZeneca PLC reported a gross profit of 12.39B and revenue of 15.50B. Therefore, the gross margin over that period was 79.9%.

ASTE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Astec Industries, Inc. reported an operating income of 22.90M and revenue of 400.60M, resulting in an operating margin of 5.7%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AstraZeneca PLC reported an operating income of 2.98B and revenue of 15.50B, resulting in an operating margin of 19.2%.

ASTE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Astec Industries, Inc. reported a net income of 12.00M and revenue of 400.60M, resulting in a net margin of 3.0%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AstraZeneca PLC reported a net income of 2.33B and revenue of 15.50B, resulting in a net margin of 15.0%.